HUM
48
-4
TRV
36
3
SYF
83
-2
ITW
58
2
WHR
68
-4
XEL
57
4
MAS
75
8
CTAS
50
2
KMB
37
-2
RL
72
3
BAX
51
-2
T
56
2
PH
77
2
AEE
66
3
CMA
77
2
USB
64
2
MA
64
4
ORCL
67
2
IPG
54
2
BIIB
53
-2
HUM
48
-4
TRV
36
3
SYF
83
-2
ITW
58
2
WHR
68
-4
XEL
57
4
MAS
75
8
CTAS
50
2
KMB
37
-2
RL
72
3
BAX
51
-2
T
56
2
PH
77
2
AEE
66
3
CMA
77
2
USB
64
2
MA
64
4
ORCL
67
2
IPG
54
2
BIIB
53
-2
Financhill
Back

Structure Therapeutics Stock Predictions

Slow Market? Try This Instead

See how it works now.
Sell
23

GPCR
Structure Therapeutics

Last Price:
$20.39
Seasonality Move:
15.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Summer Trading Shortcut

Try it free today.

Structure Therapeutics Stock Forecast

  • Over the next 52 weeks, Structure Therapeutics has on average historically fallen by 26.4% based on the past 2 years of stock performance.
  • Structure Therapeutics has fallen lower in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Structure Therapeutics Stock Undervalued?
    The current Structure Therapeutics [GPCR] share price is $20.37. The Score for GPCR is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Structure Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Structure Therapeutics has on average historically fallen by 26.4% based on the past 2 years of stock performance.

Structure Therapeutics Stock Rating

Sell
23
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics overpriced?

  • Structure Therapeutics has fallen lower in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Structure Therapeutics Stock Price History

Is GPCR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
structuretx.com

52-Week Data

52-Week High:
47.48
52-Week Low:
13.22

Prediction Charts

Market Cap:
1.2B
Price in USD:
20.37
Volume:
372.5K
Beta:
-1.96

Technical Analysis

SMA50:
23.23
SMA100:
21.93
SMA200:
28.09
52-Wk Change:
-45.62%

Stock Predictions

  • Is Structure Therapeutics stock public?
    Yes, Structure Therapeutics is a publicly traded company.
  • What is the Structure Therapeutics stock quote today?
    The Structure Therapeutics stock price is 20.37 USD today.
  • How to buy Structure Therapeutics stock online?
    You can buy Structure Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-13 21.60 21.68 22.45 21.26
Jun-16 21.57 20.57 21.97 20.56
Jun-17 20.50 20.97 21.48 20.42
Jun-18 21.07 21.62 21.78 20.71
Jun-20 22.00 21.73 22.33 21.04
Jun-23 21.91 22.10 22.89 20.91
Jun-24 22.16 22.38 23.67 21.64
Jun-25 22.42 21.79 22.42 21.02
Jun-26 21.73 21.08 22.11 20.70
Jun-27 21.25 21.08 21.68 20.87
Jun-30 21.14 20.74 21.25 20.65
Jul-1 20.67 20.51 21.40 20.35
Jul-2 20.60 20.44 21.40 20.35
Jul-3 20.43 20.37 20.81 19.83

Structure Therapeutics Earnings

Structure Therapeutics Earnings Report: Per Share Structure Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Structure Therapeutics Forecast Revenue Growth

Structure Therapeutics Stock Analysis: Historical quarterly revenues per share for Structure Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.78 per share.

* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.